Fate of Patients with Newly Diagnosed Acute Myeloid Leukemia Who Fail Primary Induction Therapy Megan Othus, Frederick R. Appelbaum, Stephen H. Petersdorf, Kenneth J. Kopecky, Marilyn Slovak, Thomas Nevill, Joseph Brandwein, Richard A. Larson, Patrick J. Stiff, Roland B. Walter, Martin S. Tallman, Leif Stenke, Harry P. Erba Biology of Blood and Marrow Transplantation Volume 21, Issue 3, Pages 559-564 (March 2015) DOI: 10.1016/j.bbmt.2014.10.025 Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions
Figure 1 Flowchart of S0106 patients included in the analysis. Biology of Blood and Marrow Transplantation 2015 21, 559-564DOI: (10.1016/j.bbmt.2014.10.025) Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions
Figure 2 Flowchart of S0106 patients who failed induction after protocol therapy. Biology of Blood and Marrow Transplantation 2015 21, 559-564DOI: (10.1016/j.bbmt.2014.10.025) Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions
Figure 3 Survival of full induction failure cohort. Biology of Blood and Marrow Transplantation 2015 21, 559-564DOI: (10.1016/j.bbmt.2014.10.025) Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions
Figure 4 Survival after failure stratified by transplant. Biology of Blood and Marrow Transplantation 2015 21, 559-564DOI: (10.1016/j.bbmt.2014.10.025) Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions
Figure 5 Survival after transplant stratified by CR at time of transplant (yes versus no), donor (matched related versus not), conditioning regimen intensity (myeloablative versus reduced intensity), and cytogenetic risk (intermediate versus unfavorable). Biology of Blood and Marrow Transplantation 2015 21, 559-564DOI: (10.1016/j.bbmt.2014.10.025) Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions